{{Rsnum
|rsid=878131
|Gene=EYA2
|Chromosome=20
|position=47051863
|Orientation=minus
|GMAF=0.275
|Gene_s=EYA2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 54.0 | 41.6 | 4.4
| HCB | 49.6 | 44.5 | 5.8
| JPT | 51.3 | 41.6 | 7.1
| YRI | 58.9 | 35.6 | 5.5
| ASW | 56.1 | 35.1 | 8.8
| CHB | 49.6 | 44.5 | 5.8
| CHD | 46.8 | 43.1 | 10.1
| GIH | 49.5 | 40.6 | 9.9
| LWK | 60.0 | 33.6 | 6.4
| MEX | 37.9 | 60.3 | 1.7
| MKK | 59.6 | 32.1 | 8.3
| TSI | 48.0 | 44.1 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=4E-6
  |OR=17.21
  |ORtxt=[9.92-24.5] mg/dL increase
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}